59 reports

You can easily book an appointment with one online.

  • General Medicine And Specialty Medicine
  • United States
  • Forecast
  • Carl Zeiss Meditec AG
  • Cianna Medical, Inc.
  • SYMPTOMS OF NSCLC

APPROXIMATELY ONE-QUARTER OF PATIENTS HAD SQUAMOUS DISEASE (##%).

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • ORGAN TRANSPLANTATION

Corneal eye disease, which is the fourth most common cause of blindness and affects more than ## million people worldwide, require cornea transplantation.

  • General Medicine And Specialty Medicine
  • CareDx, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Thermo Fisher Scientific, Inc.

THESE BIOLOGICAL THERAPIES HAVE ALSO BEEN APPROVED FOR USE IN EYE DISEASES WITH THE DRUG LUCENTIS LEADING THE SEGMENT IN SALES.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.

THEIA-## is a multi-centre, randomized, double-masked, placebo-controlled Phase IIb/ III study that will enroll approximately ## adult patients with moderate to severe dry eye disease.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • Product Initiative
  • Boehringer Ingelheim GmbH

MIM-D## also improved common vision-related function symptoms of dry eye disease as measured via the OSDI questionnaire.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • World
  • Product Initiative

While Mabs/ biosimilars are directed against one specific type of cancer, the anti-MMP vaccine can target all types of the disease at once.

  • Autoimmune Disease
  • Lung Cancer
  • World
  • Product Initiative
  • Gilead Sciences, Inc.

The NFS remained stable in both patients over one year, suggesting a durable halt in disease progression.

  • Endocrine Disease
  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • Ampio Pharmaceuticals, Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The first study enrolled patients with neurotrophic keratitis in only one eye, while the second study involved subjects who were affected in both eyes.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • Product Initiative
  • Loxo Oncology, Inc.

It offers products for treating cancer, cerebrovascular and cardiovascular, infections, psychological and neurological system, respiratory system and eye diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Monoclonal Antibody
  • Prostate Cancer
  • Amgen Inc.

THEIA-## is a multi-centre, randomized, double-masked, placebo-controlled Phase IIb/ III study that will enroll approximately ## adult patients with moderate to severe dry eye disease.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • Product Initiative
  • Boehringer Ingelheim GmbH

It offers products for treating cancer, cerebrovascular and cardiovascular, infections, psychological and neurological system, respiratory system and eye diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Monoclonal Antibody
  • Prostate Cancer
  • Amgen Inc.

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Medical Biotechnology
  • United States
  • Product Initiative

The company also offers TOP##, a candidate used in treatment of dry eye diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Oncology
  • World
  • Boehringer Ingelheim GmbH

The drug candidate is in Phase II stage of development for diabetic macular edema (DME or diabetic eye disease).

  • Cancer
  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • Bristol-Myers Squibb Company

Feldan products are used in the treatment of skin, eye and lung diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative

Charles Theuer, president and CEO of Tracon, said, " TRC## has the potential to help patients suffering from serious and debilitating eye diseases who do not benefit from current treatment.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Pharmaceutical
  • United States
  • TRACON Pharmaceuticals, Inc.

One patient had stable disease at Month ##.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative

One patient had stable disease at Month ##.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY NOVARTIS AG, H2 2018
  • PIPELINE BY MERCK & CO INC, H2 2018

The company' s six US FDA-approved medicines and product candidates in development help patients with eye diseases, asthma, pain, cancer and heart, allergic, inflammatory and infectious diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Medical Biotechnology
  • United States
  • Bristol-Myers Squibb Company

The drug candidate is also in preclinical stage of development for the treatment of eye diseases.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • Merck & Co., Inc.
  • GL-101 - DRUG PROFILE

One patient had stable disease and one patient had progressive disease.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • North America
  • United States
  • Product Initiative

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • Bristol-Myers Squibb Company

The company also offers TOP##, a candidate used in treatment of dry eye diseases.

  • Cancer
  • General Medicine And Specialty Medicine
  • Lung Cancer
  • World
  • Boehringer Ingelheim GmbH

The company' s products are used to treat pain, sepsis, lung fibrosis and other organ fibrosis, bone diseases, and eye diseases and inflammatory disorders.

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • Bristol-Myers Squibb Company
  • PIPELINE BY NOVARTIS AG, H2 2019

ITS MARKETED AND PIPELINE PRODUCTS ARE FOCUSED ON HELPING PATIENTS SUFFERING WITH EYE DISEASES, CANCER, ALLERGIC AND INFLAMMATORY DISEASES, METABOLIC AND CARDIOVASCULAR DISEASES, INFECTIOUS DISEASES, NEUROMUSCULAR DISEASES, AND RARE DISEASES.

  • General Medicine And Specialty Medicine
  • Immunotherapy
  • Lung Cancer
  • Therapy
  • Bristol-Myers Squibb Company
  • PIPELINE BY OSE IMMUNOTHERAPEUTICS, H2 2019
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Therapy
  • United States
  • Alpine Immune Sciences, Inc.

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • General Medicine And Specialty Medicine
  • Immunotherapy
  • Lung Cancer
  • Monoclonal Antibody
  • Bristol-Myers Squibb Company

As a promising topical anti - inflammatory agent, TOP## aims to improve the signs and symptoms of dry eye disease, one of the most common eye diseases, where current therapy remains inadequate for all but the mildest of cases. "

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • United States
  • Product Initiative
  • Boehringer Ingelheim GmbH

Only one patient had progressive disease.

  • General Medicine And Specialty Medicine
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Hanmi Science Co., Ltd.